SHAUNA RICHARDSON: Open Payments
NPI 1447206511 · KENOSHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,503 in 95 payments from 17 companies in 2025. Trend: 2023 $1,330 · 2024 $1,157 · 2025 $1,503
Food & beverage: $1,432Education: $71
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 17 | $300 |
| Supernus Pharmaceuticals, Inc. | 22 | $260 |
| Axsome Therapeutics, Inc. | 17 | $167 |
| Alkermes, Inc. | 8 | $163 |
| Neurocrine BioSciences, Inc. | 5 | $102 |
| ABBVIE INC. | 5 | $94 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| HARMONY BIOSCIENCES LLC | 2 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Lundbeck LLC | 2 | $44 |
Products named: Qelbree, AUSTEDO XR, Auvelity, ARISTADA, INGREZZA, VRAYLAR, REXULTI, WAKIX.
Industry payments across WI — which companies pay providers there.
